1Suhana A, Smith C Tudur, Cunningham D, et al. Systmatic review, including meta analysis, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy [ J ]. Br J Cancer,2007,96 ( 8 ) : 1183 - 1190.
2Jemal A,Siegel R, Ward E, et al. Cancer statistics, 2008 [ J ]. CA Cancer J Clin, 2008, 58(2) : 71 -96.
3Johnson CD. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas [ J ]. Gut, 2005,54( suppl 5 ) : v1 - 16.
4Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemeitabine as first - line therapy for patients with advanced pancreas cancer: a randomized trial [ J ]. J Clin Oneol, 1997,15 (6) : 2403 - 2413.
5SuhanaA, SmlthCT, Cunningham D, et al. Meta - analyses of chemotherapy for locally advanced and metastatic pancreatic cancer[ J]. J Clin Oncol,2007,25 ( 18 ) : 2607 - 2615.
6Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer [ J ]. Gut, 2007,56 ( 8 ) : 1134 - 1152.
7Taipale J, Beachy PA. The Hedgehog and Wnt signaling pathways in cancer[ J ]. Nature ,2001,411 (6835) : 349 - 354.
8Tseng JF, Farnebo FA, Kisker O, et al. Adenovirus - mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice[ J]. Surgery, 2002,132 ( 5 ) : 857 - 865.
9Kim D. Replication -selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer [ J ]. Oncogene,2000,19 (56) : 6660 - 6669.
10Lindenmann J, Klein PA. viral oncolysis: increased imunogeniciy of host cell antigen associated with influenza virus[J]. J Exp Med, 1967,126( 1 ) : 93 - 108.
